Milan, Italy

Paolo Ghirardi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1983-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paolo Ghirardi: Innovator in Pharmaceutical Compositions

Introduction

Paolo Ghirardi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compositions. With a total of two patents to his name, Ghirardi's work focuses on innovative solutions for treating serious health conditions.

Latest Patents

Ghirardi's latest patents include "Epinine and the therapeutic use thereof" and "Creatinol-O-phosphates having therapeutical action." The first patent involves pharmaceutical compositions that contain epinine or its pharmaceutically acceptable salts. These compositions are designed to achieve a release of epinine between 0.5 and 5 µg/Kg/minute. They are particularly useful in treating congestive heart failures, as they stimulate heart contractility and exhibit vasodilating and bronchodilating activities without causing adverse effects. The second patent focuses on the magnesium salt of creatinol-O-phosphate, which is beneficial in the treatment and prevention of myocardial infarction. This magnesium salt can be prepared in either anhydrous or hydrated form and is suitable for normal pharmaceutical formulations for both oral and parenteral administration.

Career Highlights

Throughout his career, Paolo Ghirardi has worked with several companies, including Simes S.p.a. and Simes Società Italiana Medicinali e Sintetici S.p.a. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Ghirardi has collaborated with notable individuals in the field, including Cesare Casagrande and Theophile Godfraind. These collaborations have likely enriched his research and development efforts.

Conclusion

Paolo Ghirardi is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of heart conditions and myocardial infarction. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…